VivaVision Biotech reveals promising phase 2 trial results for VVN461, a new treatment for Non-Infectious Anterior Uveitis, ...

CsA Ophthalmic Gel is an innovative cyclosporine gel being developed by Zhaoke in China for the treatment of moderate to ...

Full abstracts will be released by ASCO on Thursday, May 22, 2025, at 5:00 PM ET. Details from the presentations will be ...

Analysts displayed cautious optimism, focusing on the progress of clinical trials and upcoming ... and manufacturing agreements for Phase 3 trials. The current quarter saw heightened activity ...

In a phase 3, double-blind trial ... Safety was monitored from the time of enrollment through the end of the trial by means of clinical laboratory tests, vital sign measurements ...

Novocure (NVCR) announced that it will present additional results from the Phase 3 PANOVA-3 trial of its Tumor Treating Fields therapy for ...

"On behalf of Renibus and the clinical study team ... enrollment and administration of RBT-1 in its PROTECT Phase 3 pivotal trial and announced completion of enrollment in April 2025.

ORCA-3 was the second randomized, placebo-controlled Phase 3 clinical trial evaluating cytisinicline for smoking cessation in 792 U.S. adults. The authors concluded that ORCA-3 reaffirms ...

Q1 2025 Management View CEO Brian Lian highlighted the company's progress in advancing its VK2735 obesity program, with Phase ...

"This level of cooperation will streamline trial operations ... advance its Phase 3 program," said Kimball A. Johnson, M.D., Medical Director of CenExel iResearch Atlanta. "Cedar Clinical Research ...

Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to address the ...

ORCA-3 Demonstrated a Significant Increase in Quitting and Reduction in Nicotine Cravings for Cytisinicline-Treated Participants Compared to Placebo Cytisinicline New Drug Application (NDA) Submission ...